GlassScriptPhysician profile
Younus Rakla
NPI 1104876499
$974.86
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $226 · 2021: $211 · 2022: $211.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $322.56 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $172.39 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $108.91 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $99.99 | 2019-2022 | |
| Abbott Laboratories | $54.28 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $38.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.94 | 2022 | |
| Medtronic Vascular, INC. | $30.97 | 2019 | |
| Boston Scientific Corporation | $16.56 | 2019 | |
| Novo Nordisk INC | $15.70 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.78 | 2021 | |
| Lilly USA, LLC | $14.19 | 2021 | |
| Esperion Therapeutics, INC. | $14.05 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.45 | 2019 | |
| Allergan, INC. | $12.42 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $11.54 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Younus Rakla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.